In neural injury models, microglial activation decreases and CD206-expressing phenotypes emerge[5][6]
These include: Gastroparesis (Stomach Paralysis): This severe side effect, leading to delayed stomach emptying, causes nausea, vomiting, and intense abdominal pain
GIP receptor activation: Works synergistically with GLP-1 to improve glucose metabolism and enhance the satiety signal
NSL literature pointer PMID 12517428 L-Carnitine laboratory index [PMID: 12517428] National Science Labs indexing note for PMID 12517428: review the PubMed methods, models, and limitations before citing
A doctor can provide guidance on appropriate dosage, dietary support, and potential interactions with other treatments
While current human observational data provide reassuring safety profiles and highlight metabolic advantages, true evidence for intrinsic disease modification remains limited and heavily confounded by systemic weight loss